Takaishi, Japan

Akira Minamida


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1991-1992

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Akira Minamida: Innovator in Antibacterial Agents

Introduction

Akira Minamida is a notable inventor based in Takaishi, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial agents. With a focus on quinoline derivatives, his work has the potential to impact healthcare positively.

Latest Patents

Minamida holds 2 patents related to his innovative research. His latest patents include "Quinoline derivatives and antibacterial agent containing them," which describes a quinoline derivative with specific structural characteristics that exhibit excellent antibacterial activity. The compounds developed in this patent are useful as antibacterial agents. Another significant patent is for "Oxo quinoline derivatives," which also details a quinoline derivative with similar structural features and antibacterial properties.

Career Highlights

Minamida is associated with Dainippon Pharmaceutical Company, Limited, where he continues to advance his research in antibacterial agents. His work is characterized by a commitment to developing effective solutions for combating bacterial infections.

Collaborations

Throughout his career, Minamida has collaborated with esteemed colleagues, including Jun-ichi Matsumoto and Masahiro Fujita. These collaborations have fostered a productive research environment, leading to innovative discoveries in the field.

Conclusion

Akira Minamida's contributions to the development of antibacterial agents through his patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…